| Drug Name: | Rescinnamine (24815-24-5) |
|---|---|
| PubChem ID: | 5280954 |
| SMILES: | CO[C@H]1[C@@H](C[C@@H]2CN3CCC4=C([C@H]3C[C@@H]2[C@@H]1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)/C=C/C6=CC(=C(C(=C6)OC)OC)OC |
| InchiKey: | SZLZWPPUNLXJEA-QEGASFHISA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 634.726 |
| LogP | : | 4.5707 |
| Ring Count | : | 3 |
| Hydrogen Bond Acceptor Count | : | 10 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 117.78 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Dysuria | Sodium-dependent noradrenaline transporter (P23975) | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
| Nasal Congestion | Sodium-dependent noradrenaline transporter (P23975) | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|